Sakuragaoka Hospital

What Sakuragaoka Hospital does

Sakuragaoka Hospital is a specialized psychiatric hospital (221 beds, four wards) operated by Tokutei Iryouhoujin Tomio-kai in Kumamoto City, Kumamoto Prefecture, Japan. Founded in 1960 as Tomio-en Sanatorium and renamed in 1994, the hospital provides comprehensive mental health care across depression (including a 76.7% six-month return-to-work rate via its certified Rework Rehabilitation Center), treatment-resistant schizophrenia (clozapine treatment with Akita University-partnered blood concentration monitoring and >10 years of clinical experience), dementia (newly registered Dementia Treatment Ward, May 2025), and addiction disorders. The hospital delivers an integrated treatment system combining drug therapy (including m-ECT using a Thymatron device since 2004/2016), psychotherapy, and a German Tannenhof-model occupational therapy program.

The hospital's service ecosystem extends well beyond inpatient care to include two satellite psychiatric clinics (Shinmachi Mental Clinic opened 2018, Suizenji Kokoro Clinic opened April 2023), two home-visit nursing stations (Raifu since 2000, Tomoni since 2019), a group home with 11 residents (since 2003), general daycare, and a certified depression return-to-work daycare. Approximately 70% of inpatients arrive via clinic and hospital referrals across Kumamoto Prefecture. The hospital was designated a Disaster Base Psychiatric Hospital with DPAT dispatch capability in 2022, and is the 13th nationally certified Japan Depression Rework Association facility (2023). Leadership transitioned in 2023 with new Chairman Akagi Kenri and new Hospital Director Ooisu Hiroaki.

Revenue is generated through Japanese national health insurance reimbursement across inpatient (acute psychiatric, general psychiatric, dementia, and depression wards), outpatient, daycare, home-visit nursing, and residential services. Pricing is regulated under the public insurance system, with limited private/specialty room surcharges (¥2,100-¥8,380/day). The hospital is a privately held specified medical corporation with no external PE/VC involvement, no disclosed funding rounds, and no public ticker. No AI/ML capabilities, patents, or proprietary software products are evident in the disclosed materials.

Name

Sakuragaoka Hospital

Legal name

特定，富尾会 桜が丘病院 (Tokutei Iryouhoujin Tomio-kai Sakuragaoka Byouin)

Website

https://sakuragaoka.or.jp

Company type

Private

Founded year

1960

Operating status

Operating

Short description

Sakuragaoka Hospital is a 221-bed psychiatric specialty hospital in Kumamoto City, Japan, operated by a specified medical corporation. It provides inpatient, outpatient, daycare, home-visit nursing, and residential services for depression, schizophrenia, dementia, and addiction, supported by two satellite clinics and certified return-to-work and disaster-response programs.

Ownership category

akta.pro rank

Product category

Psychiatric Hospital Services

NAICS

Psychiatric and Substance Abuse Hospitals (622210), Nursing Care Facilities (Skilled Nursing Facilities) (623110), Residential Mental Health and Substance Abuse Facilities (62322)

SIC

Services-Hospitals (8060), Services-Skilled Nursing Care Facilities (8051), Services-Home Health Care Services (8082)

akta.pro industry

PRIMARYHLAFAHAH

Inpatient Psychiatric Hospitals

Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care

SECONDARYHLAFACAB

Inpatient Psychiatric Hospitals & Units

Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment

SECONDARYHLADACAC

Memory Care Units within Skilled Nursing Facilities (SNF/Nursing Homes)

Healthcare & Life Sciences/Elder Care & Long-Term Care/Memory Care (Dementia/Alzheimer’s) Communities

Keywords

• Psychiatric hospital services
• Mental health treatment
• Depression care
• Dementia treatment
• Psychiatric rehabilitation

Headquarters

HQ city

Kumamoto

HQ country

Japan

HQ region

Asia

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. 入院医療報酬（精神病床・急性期治療病床・認知症治療病床）: 許可病床221床（4病棟体制）。精神病棟入院基本料（15対1）109床、精神科急性期治療病棟54床、認知症治療病棟58床として各々の入院基本料算定による保険診療報酬
2. 外来診療報酬: 外来診察（完全予約制）に基づく保険診療報酬。3割負担の方で約3,000円以下の診察代
3. デイケア・リワークプログラム報酬: 一般デイケアおよび復職支援リワークデイケアの提供。医療保険または自立支援医療が適用され、3割負担の場合1日約2,500円、半日約1,200円（自立支援医療使用時：1日約800円、半日約400円）
4. 訪問看護報酬: 訪問看護ステーションらいふ・ともにによる在宅訪問看護の保険診療報酬
5. 各種証明書・診断書発行手数料: 診断書・証明書発行手数料。診断書種類により¥1,100〜¥11,000
6. 個室・特別室料金（追加自己負担）: 特別室・個室の部屋タイプ別に追加料金。A室（1人部屋）：¥8,380/日、B室：¥4,720/日、C室：¥3,670/日、D室：¥3,060/日、E室（2人部屋）：¥2,100/日

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

Sakuragaoka Hospital is a private psychiatric specialty hospital in Kumamoto, Japan, providing inpatient, outpatient, daycare, home-visit nursing, and residential mental health services. It operates 221 licensed beds across four wards (general psychiatric, acute psychiatric, depression treatment, and dementia treatment) and supports patients across the care continuum from acute intervention to community reintegration, with specialized programs including modified electroconvulsive therapy (m-ECT), clozapine therapy, a certified depression return-to-work (rework) daycare program, and dementia care.

Product overview

Sakuragaoka Hospital operates as a specialized psychiatric hospital offering a comprehensive mental health care system. The hospital provides inpatient psychiatric treatment across four wards (221 beds) including general psychiatric care, acute depression treatment, and dementia treatment, complemented by outpatient clinics, daycare rehabilitation programs including a certified rework (return-to-work) program for depression patients, and community-based services including two visiting nursing stations and group homes. The hospital also operates two satellite clinics (Shinmachi Mental Clinic and Suizenji Kokoro Clinic) to extend psychiatric services to the broader community. Treatment approaches include drug therapy, modified ECT, clozapine treatment for resistant schizophrenia, and occupational therapy.

Differentiator

Problem solved

Functional benefit

Brands

• リワーク・リハビリテーション・センター桜が丘 (Rework Rehabilitation Center Sakuragaoka, RRC): A specialized depression return-to-work (リワーク) daycare program certified by the Japan Depression Rework Association, launched in November 2007 (H19.11) to support patients aiming to return to work after depression-related leave.
• 訪問看護ステーションらいふ (Home-visit Nursing Station Raifu)
• 訪問看護ステーションともに (Home-visit Nursing Station Tomoni)

Products and services

• General Outpatient Treatment (外来治療)
• Inpatient Psychiatric Treatment (入院治療)
• General Daycare (一般デイケア)
• Rework Rehabilitation Center / Depression Return-to-Work Support Daycare (RRC)
• Dementia Treatment (認知症治療)
• Modified Electroconvulsive Therapy (m-ECT) (修正型電気けいれん療法)
• Clozapine Treatment (クロザピン療法)
• Occupational Therapy (作業療法)
• Outreach Support (アウトリーチ)
• Visiting Nursing Station Raifu (訪問看護ステーションらいふ)
• Visiting Nursing Station Tomoni (訪問看護ステーションとともに)
• Group Home Dai-ni Irihi Tei (グループホーム 第二入江ハイツ)
• Shinmachi Mental Clinic (新町メンタルクリニック)
• Suizenji Kokoro Clinic (水前寺こころのクリニック)
• Psychological Testing and Counseling (心理検査・心理教育・カウンセリング)

Quantifiable outcome

• 修了者の6ヶ月就労継続率76.7%
• +5 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators8 records

Recent moves13 records

Expansion highlights6 records

Direct peers

• Todoroki Hospital: Todoroki Hospital is a Tokyo-based psychiatric specialty hospital providing inpatient psychiatric care and specialized treatment programs. Comparable as a Japanese urban/suburban psychiatric specialty hospital with multi-disciplinary team approach.
• Nanko Hospital: Nanko Hospital is a Japanese psychiatric specialty hospital in Wakayama Prefecture operating comparable multi-disciplinary inpatient psychiatric services, including treatment-resistant cases. Directly comparable as a regional Japanese psychiatric specialty hospital of similar scale and care model.
• Suzukake Hospital: Suzukake Hospital is a Japanese psychiatric specialty hospital offering inpatient, outpatient, and community-based mental health services. Comparable as a regional Japanese psychiatric specialist with similar service breadth across the care continuum.

Others

• Eisai Co., Ltd. Eisai is a major Japanese pharmaceutical company with a leading global dementia drug franchise (including donepezil). Thematically related to Sakuragaoka's dementia treatment program but operates in pharmaceuticals rather than inpatient services — adjacent value chain participant rather than competitor.
• Sumitomo Pharma Co., Ltd. Sumitomo Pharma is a Japanese pharmaceutical company with a substantial CNS and psychiatric drug franchise. Thematically related to Sakuragaoka's clinical specialties but operates as a drug manufacturer rather than a hospital provider — adjacent ecosystem participant.

Broad incumbents

• Otsuka Holdings: Otsuka Holdings is a major Japanese pharmaceutical group with a globally leading psychiatric and CNS drug portfolio (including aripiprazole). Comparable as a broad Japanese healthcare incumbent strongly focused on the psychiatric therapeutic area, though operating in pharmaceuticals rather than hospital services.
• Kirin Holdings: Kirin Holdings is a major Japanese healthcare and beverage conglomerate with significant pharmaceutical operations (Kyowa Kirin) including central nervous system therapeutics. Comparable as a broad Japanese healthcare incumbent with mental health adjacency, though not a direct hospital operator.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sakuragaoka Hospital